OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,937 | +1168.3% | 14,003 | +827.4% | 0.00% | – |
| Q2 2023 | $13,635 | +1004.0% | 1,510 | +324.2% | 0.00% | – |
| Q1 2023 | $1,235 | -87.7% | 356 | -91.3% | 0.00% | – |
| Q4 2022 | $10,015 | +43.1% | 4,088 | +68.2% | 0.00% | – |
| Q3 2022 | $7,000 | – | 2,431 | +9250.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 26 | -80.0% | 0.00% | – |
| Q4 2021 | $1,000 | -95.2% | 130 | -79.6% | 0.00% | – |
| Q1 2021 | $21,000 | -99.2% | 636 | -98.8% | 0.00% | -100.0% |
| Q4 2020 | $2,560,000 | – | 53,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |